|
Sharma, R P; Martis, B; Davis, J M et al. (2001) Tiagabine, a specific gamma-aminobutyric acid transporter-1 inhibitor, in the treatment of psychosis. J Clin Psychopharmacol 21:347-9
|
|
Sharma, R P; Martis, B; Rosen, C et al. (2001) CSF thyrotropin-releasing hormone concentrations differ in patients with schizoaffective disorder from patients with schizophrenia or mood disorders. J Psychiatr Res 35:287-91
|
|
Sharma, R P; Dowd, S M; Janicak, P G (1999) Hallucinations in the acute schizophrenic-type psychosis: effects of gender and age of illness onset. Schizophr Res 37:91-5
|
|
Sharma, R P; Singh, V; Janicak, P G et al. (1999) The prolactin response to fenfluramine in schizophrenia is associated with negative symptoms. Schizophr Res 39:85-9
|
|
Sharma, R P; Javaid, J I; Davis, J M et al. (1998) Pretreatment plasma homovanillic acid in schizophrenia and schizoaffective disorder: the influence of demographic variables and the inpatient drug-free period. Biol Psychiatry 44:488-92
|
|
Sharma, R P; Shapiro, L E; Kamath, S K et al. (1997) Acute dietary tryptophan depletion: effects on schizophrenic positive and negative symptoms. Neuropsychobiology 35:5-10
|
|
Sharma, R P; Janicak, P G; Bissette, G et al. (1997) CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder. Am J Psychiatry 154:1019-21
|
|
Sharma, R P; Dowd, S M; Davis, J M et al. (1996) Age of illness onset and schizophrenic symptomatology during an inpatient washout period. Schizophr Res 20:295-300
|
|
Sharma, R P; Faull, K; Javaid, J I et al. (1995) Cerebrospinal fluid levels of phenylacetic acid in mental illness: behavioral associations and response to neuroleptic treatment. Acta Psychiatr Scand 91:293-8
|
|
Sharma, R P; Bissette, G; Janicak, P G et al. (1995) Elevation of CSF somatostatin concentrations in mania. Am J Psychiatry 152:1807-9
|
